Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis
Introduction. Treatment of patients with ulcerative colitis (UC) requires continuous anti-relapse therapy. Mesalazines are the firstline disease-modifying drugs for the treatment of mild to moderate UC to manage exacerbations and to induce and maintain remission.This paper is aimed at comparing the...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Russo |
| Хэвлэсэн: |
Remedium Group LLC
2021-05-01
|
| Цуврал: | Медицинский совет |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.med-sovet.pro/jour/article/view/6177 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|